Tamara Fraizer is an attorney with Squire Patton Boggs in Palo Alto, California, who helps her clients assess intellectual property (IP) related issues, leverage and enforce IP rights and defend against IP claims. Her expertise is patent litigation and she has litigated numerous patent cases in federal courts across the nation and at the US International Trade Commission. She is also a patent lawyer qualified to prosecute patents before the US Patent and Trademark Office (PTO) and handle post-grant challenges to them. In addition to fighting for her clients in the courts and at the PTO, Tamara relies upon over 16 years of legal experience to provide her clients with sound IP assessments and counseling, and to help them effectively manage their IP disputes.
Tamara’s experience spans a variety of industries including life sciences, medical device, data analytics, pharmaceuticals, healthcare-related consumer products and software. She holds a PhD in Population Biology, which involves mathematical modeling of biological systems, and has active interests in digital health, bioinformatics and personalized medicine.
Tamara has litigated for and advised private businesses of all sizes, as well as the largest public corporations. She understands the strategic challenges that such companies face in developing and enforcing their patent portfolios, especially in competitive situations, and in defending against patents asserted by companies of all kinds. She works closely with her clients to understand their priorities and manage legal disputes with their business and overall goals in mind.
As a former university lecturer, Tamara enjoys speaking on IP law topics and mentoring younger lawyers. She also enjoys counseling entrepreneurs and start-ups on their IP strategy, helping position them for success.
Represented a medical device company in assertion of patent on systems and methods for radiotherapy treatment, coordinated the handling of proceedings between the same parties in the US, UK, Germany and the US PTO, and worked with the client to settle all matters.
Represented a healthcare product company in assertion of patents on cold compression therapy and assisted with prosecution of patents. Case settled.
Represented a pharmaceutical company in assertion of newly issued patents on an ophthalmic NSAID formulation against three companies having generic versions already on the market. All cases settled favorably late in discovery or after Markman order.
Represented a biotechnology company, taking over longstanding litigation between the parties after appeal to the Federal Circuit. Conducted trial focused on inventorship of RNase H minus reverse transcriptase and potential damages. Case settled during trial.
Articles in the National Law Review database by Tamara Fraizer Ph.D.